“With regards to emerging HIV research, all bets are off,” Jenna* told me over the phone last week. As the director of a multimillion dollar AIDS charity, she should know. “Five years ago, if you would have said that a man could be cured of HIV through an experimental stem cell transplant, and that treatment as prevention would be one of the hottest topics in the field, no one would have believed you.”
The scores of university-based scientists creating novel approaches to eliminate HIV are suddenly more attractive after a previously unknown doctor in Berlin cured Timothy Brown of AIDS through a novel bone marrow transplant. What could other nontraditional approaches do for our ability to fight AIDS? What will the next great leap forward be, and how can we make sure it gets tested ASAP?
Beta. Initial Form 1-A only. Target raise is the stated Amount to be Raised, totaled. Compared with the same dates one year earlier.
YTD: Jan 1, 2026 - Oct 24, 2026 vs Jan 1, 2025 - Oct 24, 2025
Share this graph
Number of Filings131Prior 126 +4.0%
Target Raise, Total$3.40BPrior $3.54B -3.9%
This YTD
Year prior
Change
Filings
131
126
+4.0%
Target raise
$3.40B
$3.54B
-3.9%
Sponsored by
the Crowded Media Group
the leading digital news service covering the global Fintech Industry, including digital assets, crowdfunding, tokenization, and other innovations in capital markets. email us@CrowdfundInside
This display counts initial Form 1-A filings only. It does not represent subsequent filings, including Form 1-A/A amendments or Form 1-A POS post-qualification updates filed by the issuer. Amounts are the stated Amount to be Raised on the initial filing, not capital raised and not amounts revised in later filings.
Crowdfund Insider is the leading news website covering the emerging global industry of disruptive finance including investment crowdfunding, Blockchain, online lending, and other forms of Fintech.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it and agree to our terms of service.
